ATRX and neoplasm: Authors analyzed mutations in IDH1, IDH2, TP53, TERT, ATRX, H3F3A, and HIST1H3B across two diffuse glioma cohorts from The Cancer Genome Atlas (TCGA), totaling 648 tumor samples.